Pharma Industry News

“Molecular profiling” could be key to new liver disease treatments

Identifying new treatments for liver scarring is “critical” to tackling the epidemic of liver disease.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]